Skip to content

Synergy Between PCI With TAXUS and Cardiac Surgery: SYNTAX Extended Survival

Synergy Between PCI With TAXUS and Cardiac Surgery: SYNTAX Extended Survival

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT03417050
Acronym
SYNTAXES
Enrollment
2636
Registered
2018-01-31
Start date
2016-12-31
Completion date
2019-08-08
Last updated
2020-01-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Coronary Artery Disease

Keywords

coronary artery bypass grafting, percutaneous coronary intervention, drug eluting stent, survival status, long-term follow-up, complex coronary artery disease

Brief summary

An investigator-driven, retrospective study to compare long-term survival-data (10-year follow-up) of patients with coronary artery disease (CAD), previously enrolled in the SYNTAX trial, who were randomized to percutaneous coronary intervention (PCI) using a paclitaxel (TAXUS) drug-eluting-stent (DES) or coronary artery bypass grafting (CABG).

Interventions

OTHERNo intervention will take place for this retrospective and observational study.

No intervention will take place for this retrospective and observational study.

Sponsors

Erasmus Medical Center
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
RETROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
21 Years to 100 Years
Healthy volunteers
No

Inclusion criteria

Patients which have previously been enrolled in the SYNTAX trial (randomized and registry patients)

Design outcomes

Primary

MeasureTime frameDescription
Long-term survival status10-yearAll-cause death

Secondary

MeasureTime frameDescription
Cause of death10-yearCause-specific death, separated in cardiovascular and non-cardiovascular death with specific causes for cardiovascular deaths.

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 2, 2026